PRESS RELEASE published on 08/17/2026 at 02:00, 2 months 9 days ago Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, expanding industry-leading pipeline. Agreement includes cetuximab, evolocumab, belimumab biosimilars, and option for human hyaluronidase Collaboration Biosimilars Pipeline Sandoz Henlius
BRIEF published on 08/05/2026 at 07:05, 2 months 21 days ago Sandoz annonce de solides résultats financiers pour le premier semestre 2026 Augmentation Des Ventes Nettes Groupe Sandoz AG Croissance Des Biosimilaires Résultats Financiers Du Premier Semestre 2026 Amélioration De L'EBITDA De Base
BRIEF published on 08/05/2026 at 07:05, 2 months 21 days ago Sandoz Reports Strong H1 2026 Financial Results Net Sales Increase Sandoz Group AG Biosimilars Growth H1 2026 Financial Results Core EBITDA Improvement
PRESS RELEASE published on 08/05/2026 at 07:00, 2 months 21 days ago Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter. Company confirms full-year guidance amidst solid financial performance Financial Performance Guidance Sandoz H1 2026 Results Biosimilar Growth
BRIEF published on 08/03/2026 at 07:05, 2 months 23 days ago Sandoz Advances in Resolving US Generic Medicine Litigation Pharmaceutical Market Legal Resolution Sandoz Settlements US Generic Litigation Antitrust Claims
BRIEF published on 08/03/2026 at 07:05, 2 months 23 days ago Sandoz fait des progrès dans le règlement des litiges relatifs aux médicaments génériques aux États-Unis Marché Pharmaceutique Résolution Juridique Les Colonies De Sandoz Litiges Relatifs Aux Génériques Aux États-Unis Réclamations Antitrust
PRESS RELEASE published on 08/03/2026 at 07:00, 2 months 23 days ago Sandoz takes further steps to resolve legacy US generic medicine litigation Sandoz Group AG announces settlements to resolve US generic medicine litigation with 43 states & territories and indirect resellers, with no impact on financial outlook Litigation Settlements Financial Outlook Sandoz US Generic Medicine
BRIEF published on 07/29/2026 at 11:35, 2 months 28 days ago Sandoz obtient l'autorisation de commercialiser le sémaglutide au Brésil Brésil Traitement Du Diabète Approbation Réglementaire Sandoz Semaglutide
BRIEF published on 07/29/2026 at 11:35, 2 months 28 days ago Sandoz Gains Approval for Semaglutide Treatment in Brazil Brazil Regulatory Approval Diabetes Treatment Sandoz Semaglutide
PRESS RELEASE published on 07/29/2026 at 11:30, 2 months 28 days ago Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access Sandoz receives regulatory approval for Owozy®, a new semaglutide treatment for type-2 diabetes in Brazil, enhancing patient access and supporting local healthcare systems Brazil Regulatory Approval Sandoz Semaglutide Patient Access
Published on 10/26/2026 at 13:30, 4 hours 9 minutes ago Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 4 hours 39 minutes ago BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 12:30, 5 hours 9 minutes ago Longview Capital Announces Voluntary TSXV Delisting
Published on 10/26/2026 at 17:15, 23 minutes ago HKSTP Partners with Leading Science and Technology Company Merck to Open a New Chapter in I&T Collaboration
Published on 10/26/2026 at 17:00, 38 minutes ago EQS Group receives validation of its climate targets by the Science Based Targets initiative
Published on 10/26/2026 at 16:51, 47 minutes ago SoftwareOne named a Leader in the 2026 Gartner® Magic Quadrant™ for SAM Managed Services
Published on 10/26/2026 at 16:15, 1 hour 23 minutes ago Freedom Holding Corp. Advances AI Infrastructure Development in Kazakhstan
Published on 10/26/2026 at 15:18, 2 hours 20 minutes ago EQS-Adhoc: Fraport AG Frankfurt Airport Services Worldwide: Preliminary Figures 3Q 2026
Published on 10/26/2026 at 17:30, 9 minutes ago Nombre total de droits de vote et actions composant le capital social au 30 septembre 2026
Published on 10/26/2026 at 17:30, 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 11:27, 6 hours 11 minutes ago 261026 BENETEAU Transactions sur actions propres
Published on 10/26/2026 at 07:30, 10 hours 9 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 10 hours 9 minutes ago LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE